UB Paderborn / Katalog / Suche / in CDI

Factor VIII Products and Inhibitor Development in Severe Hemophilia A

The New England journal of medicine, 2013-01, Vol.368 (3), p.231-239

2013

Volltextzugriff (PDF)

Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US)

Thrombosis and haemostasis, 2013-06, Vol.109 (6), p.1170

2013

Volltextzugriff (PDF)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk

Medicina (Kaunas, Lithuania), 2023-06, Vol.59 (6), p.1169

2023

Volltextzugriff (PDF)

Letter to the Editor Regarding “Large Craniotomy Increases the Risk of Minor Perioperative Complications in Revascularization Surgery for Moyamoya Disease”

World neurosurgery, 2020-11, Vol.143, p.581-583

2020

Volltextzugriff (PDF)

Hemophilia Care in the Pediatric Age

Journal of clinical medicine, 2017-05, Vol.6 (5), p.54

2017

Volltextzugriff (PDF)

Clinical Data of Neonatal Systemic Thrombosis

The Journal of pediatrics, 2016-04, Vol.171, p.60-66.e1

2016

Volltextzugriff (PDF)

Prolongated Activated Partial Thromboplastin Time (aPTT) in Pediatric Patients before Surgery-Crying Wolf: Lupus (Anticoagulant) Does Not Always Threaten Children

Journal of clinical medicine, 2024-03, Vol.13 (5), p.1510

2024

Volltextzugriff (PDF)

Lupus Anticoagulant Detection under the Magnifying Glass

Journal of clinical medicine, 2023-10, Vol.12 (20), p.6654

2023

Volltextzugriff (PDF)

Cerebrovascular disease and varicella in children

Brain & development (Tokyo. 1979), 2006-07, Vol.28 (6), p.366-370

2006

Volltextzugriff (PDF)

Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa

Diagnostics (Basel), 2022-08, Vol.12 (8), p.1999

2022

Volltextzugriff (PDF)

Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia

American journal of hematology, 2010-05, Vol.85 (5), p.325-330

2010

Volltextzugriff (PDF)

Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry

Journal of clinical medicine, 2022-04, Vol.11 (7), p.1969

2022

Volltextzugriff (PDF)

Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus

Journal of clinical medicine, 2022-02, Vol.11 (3), p.801

2022

Volltextzugriff (PDF)

Safety and effectiveness of recombinant factor XIII‐A2 in congenital factor XIII deficiency: Real‐world evidence

Research and practice in thrombosis and haemostasis, 2022-02, Vol.6 (2), p.e12628-n/a, Article e12628

2022

Volltextzugriff (PDF)

Systemic Catheter-Related Venous Thromboembolism in Children: Data From the Italian Registry of Pediatric Thrombosis

Frontiers in pediatrics, 2022-03, Vol.10, p.843643-843643

2022

Volltextzugriff (PDF)

Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors

Thrombosis and haemostasis, 2020-02, Vol.120 (2), p.216

2020

Volltextzugriff (PDF)

Successful of Immune Tolerance Induction (R-ITI) with Simoctocog Alfa (rhFVIII) in Hemophilia a Patients and High-Titer Inhibitors

Blood, 2018-11, Vol.132 (Supplement 1), p.5036-5036

2018

Volltextzugriff (PDF)

Successful Multidisciplinary Management of Aortic Valve Repair in Severe Hemophilia B with Extended Half-Life Recombinant Factor IX Concentrate

Acta haematologica, 2023-08, Vol.146 (4), p.322-325

2023

Volltextzugriff (PDF)

Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment

British journal of haematology, 2017-10, Vol.179 (2), p.298-307

2017

Volltextzugriff (PDF)

Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency

Clinical pharmacokinetics, 2022-04, Vol.61 (4), p.505-513

2022

Volltextzugriff (PDF)

Variability of treatment modalities and intensity in patients with severe haemophilia A on prophylaxis: Results from the Italian national registry

European journal of haematology, 2021-10, Vol.107 (4), p.408-415

2021

Volltextzugriff (PDF)

Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study

Thrombosis and haemostasis, 2015-07, Vol.114 (1), p.35

2015

Volltextzugriff (PDF)

Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres

British journal of haematology, 2022-02, Vol.196 (4), p.871-883

2022

Volltextzugriff (PDF)

Improving assessment and management of pain in hemophilia: an Italian Delphi consensus statement

Blood reviews, 2022-01, Vol.51, p.100885-100885, Article 100885

2022

Volltextzugriff (PDF)

F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes

Journal of thrombosis and haemostasis, 2022-01, Vol.20 (1), p.69-81

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Factor VIII Products and Inhibitor Development in Severe Hemophilia A

Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk

Letter to the Editor Regarding “Large Craniotomy Increases the Risk of Minor Perioperative Complications in Revascularization Surgery for Moyamoya Disease”

Hemophilia Care in the Pediatric Age

Clinical Data of Neonatal Systemic Thrombosis

Prolongated Activated Partial Thromboplastin Time (aPTT) in Pediatric Patients before Surgery-Crying Wolf: Lupus (Anticoagulant) Does Not Always Threaten Children

Lupus Anticoagulant Detection under the Magnifying Glass

Cerebrovascular disease and varicella in children

Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa

Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia

Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry

Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus

Safety and effectiveness of recombinant factor XIII‐A2 in congenital factor XIII deficiency: Real‐world evidence

Systemic Catheter-Related Venous Thromboembolism in Children: Data From the Italian Registry of Pediatric Thrombosis

Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors

Successful of Immune Tolerance Induction (R-ITI) with Simoctocog Alfa (rhFVIII) in Hemophilia a Patients and High-Titer Inhibitors

Successful Multidisciplinary Management of Aortic Valve Repair in Severe Hemophilia B with Extended Half-Life Recombinant Factor IX Concentrate

Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment

Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency

Variability of treatment modalities and intensity in patients with severe haemophilia A on prophylaxis: Results from the Italian national registry

Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study

Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres

Improving assessment and management of pain in hemophilia: an Italian Delphi consensus statement

F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes

Suchergebnisse filtern